Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 179,338	$ 141,666
Accounts receivable	60,587	96,043
Inventories	14,643	15,161
Deferred tax assets, net	0	1,264
Income tax receivable, net	5,651	0
Prepaid expenses and other current assets	12,896	9,213
Total current assets	273,115	263,347
Property, plant and equipment, net	264,240	241,764
In-process research and development	41,800	41,800
Intangible assets, net	30,148	0
Goodwill	13,954	5,502
Deferred tax assets, net	0	11,087
Other assets	3,373	730
Total assets	626,630	564,230
Current liabilities:
Accounts payable	27,521	31,297
Accrued expenses and other current liabilities	1,252	1,488
Accrued compensation	24,615	22,726
Contingent purchase consideration, current portion	1,341	0
Income tax payable, net	0	115
Deferred tax liability, net	88	0
Long-term indebtedness, current portion	0	4,470
Deferred revenue	1,834	1,811
Total current liabilities	56,651	61,907
Contingent purchase consideraton, net of current portion	15,278	0
Long-term indebtedness, net of current portion	62,000	58,304
Deferred tax liability, net	1,419	0
Other liabilities	2,117	1,891
Total liabilities	137,465	122,102
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at December 31, 2013 and December 31, 2012, respectively	0	0
Common stock, $0.001 par value; 100,000,000 shares authorized, 37,036,996 shares issued and 36,624,043 shares outstanding at December 31, 2013; 36,272,550 shares issued and 35,869,392 outstanding at December 31, 2012	37	36
Treasury stock, at cost, 412,953 and 403,158 common shares at December 31, 2013 and 2012, respectively	(6,119)	(5,906)
Additional paid-in capital	247,637	230,964
Accumulated other comprehensive loss	(3,465)	(4,129)
Retained earnings	251,528	220,393
Total Emergent BioSolutions Inc. stockholders' equity	489,618	441,358
Noncontrolling interest in subsidiaries	(453)	770
Total stockholders' equity	489,165	442,128
Total liabilities and stockholders' equity	$ 626,630	$ 564,230